Familial Risk for Bipolar Disorder and Alcohol Sensitivity
NCT04716036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68
Last updated 2024-07-24
Summary
Early identification in individuals with bipolar disorder who are at risk for AUDs could inform novel intervention strategies and improve life-long outcomes. The primary objective of this protocol is to use alcohol administration procedures and alcohol biosensor technology to investigate responses to alcohol, compared to placebo, and relationship with parental risk for alcohol use disorders and/or bipolar disorder in young adults. Baseline clinical, cognitive, and behavioral assessments will be completed in 100 young adults (21-26 years; 50% women, no history of AUDs\>mild). Participants would be equally divided among those with parental history of bipolar disorder but not AUDs, parental history of bipolar disorder and AUDs, parental history of AUDs but not bipolar disorder, and typically developing age- and sex-matched controls with no parental history of mood disorders or AUDs (N=25 per group). Then, while wearing Secure Continuous Remote Alcohol Monitoring \[SCRAM\] sensors, participants will complete within-person, counter-balanced, beverage sessions (following standard beverage administration procedures) in a simulated bar laboratory. Changes in heart rate, body sway and subjective self-report measurements of intoxication will also be completed while under the influence of alcohol or placebo. Specifically, individual differences in transdermal alcohol concentration (the primary data output from SCRAM sensors), physiological changes (e.g. heart rate), and the experience of stimulating, sedative, and anxiolytic effects of alcohol (measured with self-report surveys) will be investigated and differences between parental risk subgroups and healthy comparison participants investigated. Differences in transdermal alcohol concentration collected while under the influence of alcohol will be the primary data outcome assessed. Changes in heart rate, body sway, and experience of stimulating, sedative, and anxiolytic effects (from self-report survey data) while under the influence of alcohol compared to placebo session will also be investigated. Additionally, associations between objective and subjective responses to alcohol and drinking patterns will be explored (secondary outcome). The primary endpoint of the study will be after completion of both alcohol and placebo beverage conditions.
Conditions
- Bipolar Disorder
- Alcohol Drinking
- Alcohol Use Disorder
Interventions
- OTHER
-
Alcohol beverage
Participants will be provided alcohol during study visits and changes in behavior/neural activity after consuming alcohol will be examined.
- OTHER
-
Placebo beverage
placebo beverage condition.
Sponsors & Collaborators
-
University of Texas at Austin
lead OTHER
Principal Investigators
-
Elizabeth Lippard, PhD · University of Texas at Austin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 26 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-13
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-30
Countries
- United States
Study Locations
More Related Trials
-
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
NCT02082678 ·Status: COMPLETED ·Phase: PHASE4
-
Study of DCR-AUD in Healthy Volunteers
NCT05021640 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Aripiprazole in Subjects With Alcoholism
NCT00082199 ·Status: COMPLETED ·Phase: PHASE4
-
Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation
NCT07188376 ·Status: RECRUITING ·Phase: NA
-
Oxytocin and Stress Response in Alcohol Use Disorder
NCT03610633 ·Status: COMPLETED ·Phase: PHASE2
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
NCT05677321 ·Status: RECRUITING
-
Impulsivity Domains and Subjective Response
NCT05929677 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence
NCT00611767 ·Status: COMPLETED ·Phase: NA
-
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
NCT07219966 ·Status: RECRUITING ·Phase: PHASE3
-
PT150 Drug for Use in Alcohol Use Disorder
NCT06712602 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder
NCT06807918 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.
NCT00230425 ·Status: COMPLETED
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
NCT02371889 ·Status: COMPLETED ·Phase: PHASE2
-
Bipolar Disorder With Alcoholism in Han Chinese
NCT01188395 ·Status: UNKNOWN
-
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
NCT02989662 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
NCT02646449 ·Status: COMPLETED ·Phase: PHASE2
-
Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving
NCT05305404 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Enhancing the Effects of Alcohol Treatment With Lamotrigine
NCT04770493 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
Deep Brain Stimulation (DBS) for the Treatment of Refractory Alcohol Use Disorder (AUD): Pilot Trial
NCT03660124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT05223829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Nicotinic Receptor Genetic Variation and Alcohol Reward
NCT03294460 ·Status: RECRUITING ·Phase: PHASE1